<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(10)</volume><submitter>Solari FA</submitter><funding>Bundesministerium für Bildung und Forschung</funding><pubmed_abstract>The Scott syndrome is a very rare and likely underdiagnosed bleeding disorder associated with mutations in the gene encoding anoctamin-6. Platelets from Scott patients are impaired in various Ca&lt;sup>2+&lt;/sup>-dependent responses, including phosphatidylserine exposure, integrin closure, intracellular protein cleavage, and cytoskeleton-dependent morphological changes. Given the central role of anoctamin-6 in the platelet procoagulant response, we used quantitative proteomics to understand the underlying molecular mechanisms and the complex phenotypic changes in Scott platelets compared with control platelets. Therefore, we applied an iTRAQ-based multi-pronged strategy to quantify changes in (1) the global proteome, (2) the phosphoproteome, and (3) proteolytic events between resting and stimul</pubmed_abstract><journal>Molecular &amp; cellular proteomics : MCP</journal><pagination>3154-3169</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5054341</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Combined Quantification of the Global Proteome, Phosphoproteome, and Proteolytic Cleavage to Characterize Altered Platelet Functions in the Human Scott Syndrome.</pubmed_title><pmcid>PMC5054341</pmcid><pubmed_authors>Collins PW</pubmed_authors><pubmed_authors>Solari FA</pubmed_authors><pubmed_authors>Swieringa F</pubmed_authors><pubmed_authors>Zahedi RP</pubmed_authors><pubmed_authors>Mattheij NJ</pubmed_authors><pubmed_authors>Sickmann A</pubmed_authors><pubmed_authors>Burkhart JM</pubmed_authors><pubmed_authors>Cosemans JM</pubmed_authors><pubmed_authors>Heemskerk JW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Combined Quantification of the Global Proteome, Phosphoproteome, and Proteolytic Cleavage to Characterize Altered Platelet Functions in the Human Scott Syndrome.</name><description>The Scott syndrome is a very rare and likely underdiagnosed bleeding disorder associated with mutations in the gene encoding anoctamin-6. Platelets from Scott patients are impaired in various Ca&lt;sup>2+&lt;/sup>-dependent responses, including phosphatidylserine exposure, integrin closure, intracellular protein cleavage, and cytoskeleton-dependent morphological changes. Given the central role of anoctamin-6 in the platelet procoagulant response, we used quantitative proteomics to understand the underlying molecular mechanisms and the complex phenotypic changes in Scott platelets compared with control platelets. Therefore, we applied an iTRAQ-based multi-pronged strategy to quantify changes in (1) the global proteome, (2) the phosphoproteome, and (3) proteolytic events between resting and stimul</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Oct</publication><modification>2026-04-30T00:59:44.457Z</modification><creation>2019-03-27T02:26:06Z</creation></dates><accession>S-EPMC5054341</accession><cross_references><pubmed>27535140</pubmed><doi>10.1074/mcp.M116.060368</doi></cross_references></HashMap>